Monday, June 28, 2021

PharmEasy gets $300 million booster shot for Thyrocare deal

PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostics chain Thyrocare.

from Tech-Economic Times https://ift.tt/3Afitz4

No comments:

Post a Comment

Elon Musk's Tesla, SpaceX launch Terafab chips project; here's all you need to know

The project envisages setting up space-based AI computing, enabled by solar-powered satellites that could host data centres in orbit. From 1...